Intensity Therapeutics Shareholders Engage and Elect at Annual Meeting
Company Announcements

Intensity Therapeutics Shareholders Engage and Elect at Annual Meeting

Intensity Therapeutics, Inc. (INTS) has provided an announcement.

Intensity Therapeutics, Inc. successfully conducted its Annual Meeting via live webcast on July 17, 2024, where a significant 62.15% of its shareholders participated. They approved the 2024 Employee Stock Purchase Plan, elected two Class I directors for a three-year term, and ratified the appointment of EisnerAmper LLP as the company’s independent auditor for the upcoming fiscal year. These decisions reflect shareholder confidence and active engagement in the company’s future direction.

Find detailed analytics on INTS stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyIntensity Therapeutics announces first dosing in Phase 2 trial of INT230-6
TheFlyIntensity Therapeutics initiated with a Buy at H.C. Wainwright
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App